Diminished oxidation of 14C-UL-L-asparagine to 14CO2 in mice and humans with tumors: a possible means for assessing efficacy of therapy?
D000818:Animals; D001216:Asparagine / Q000378:metabolism*; D001224:Aspartic Acid / Q000378:metabolism; D002245:Carbon Dioxide / Q000378:metabolism*; D002247:Carbon Isotopes; D006801:Humans; D007275:Injections, Intravenous; D007945:Leukemia, Lymphoid / Q000378:metabolism; D008297:Male; D051379:Mice; D009101:Multiple Myeloma / Q000378:metabolism; D009369:Neoplasms / Q000188:drug therapy / Q000378:metabolism*; D009374:Neoplasms, Experimental / Q000188:drug therapy / Q000378:metabolism; D010084:Oxidation-Reduction
D002247:Carbon Isotopes; D002245:Carbon Dioxide; D001224:Aspartic Acid; D001216:Asparagine